<DOC>
	<DOCNO>NCT01039285</DOCNO>
	<brief_summary>Advances perinatal care make possible improve survival immature neonate , cost increase population risk develop bronchopulmonary dysplasia ( BPD ) . Measures attempt limit development BPD always effective , related major side effect . The physiopathological factor identify BPD , theory , respond surfactant . Therefore , use exogenous surfactant neonate present pulmonary disease require mechanical ventilation , lead significant risk BPD , allow early extubation thus promote pulmonary healing growth .</brief_summary>
	<brief_title>Exogenous Surfactant Very Preterm Neonates Prevention Bronchopulmonary Dysplasia</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Bronchopulmonary Dysplasia</mesh_term>
	<mesh_term>Infant , Premature , Diseases</mesh_term>
	<mesh_term>Pulmonary Surfactants</mesh_term>
	<mesh_term>Poractant alfa</mesh_term>
	<criteria>neonate gestational age le 33 week amenorrhea still conventional assisted ventilation HFOV ( High Frequency Oscillatory Ventilation ) , 14 Â± 2 day life active infection ( CRP &gt; 30 mg/L ) control appropriate antibiotic treatment use corticosteroid postnatal period significant neurological malformative disease surgical intervention &lt; 72 hour refusal parental approval</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>16 Days</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Very premature infant</keyword>
	<keyword>Surfactant</keyword>
	<keyword>Respiratory Distress</keyword>
	<keyword>Bronchopulmonary Dysplasia</keyword>
</DOC>